Brian Li, MD

Appointed
2021

Education & Fellowships

Fellowship - Stanford Hospital and Clinics
Interventional Cardiology
Standford, CA USA
2021

Fellowship - University of Toronto Hospitals
Interventional Cardiology
Toronto, Ontario, Canada,
2020

Residency - University of Toronto Hospitals
Adult Cardiology
Toronto, Ontario, Canada,
2019

Residency - University of Toronto Hospitals
Internal Medicine
Toronto, Ontario, Canada,
2016

Medical Education - University of Toronto
Toronto, ON Canada
2013

Undergraduate - University of Waterloo
Systems Design Engineering with Co-op
Waterloo, ON Canada
2009

Professional Highlights

• Certifications:
• ABIM-Internal Medicine
• ABIM-Cardiovascular Disease
• ABIM-Interventional Cardiology
• National Board of Echocardiography

Certifications

• Cardiology
• Internal Medicine
• Adult Transthoracic Echocardiology
• Internal Medicine - Cardiovascular Disease
• Internal Medicine
• Internal Medicine - Interventional Cardiology

Specialty Interests

Coronary Artery Disease, Chronic Total Occlusion, Acute Coronary Syndrome, Coronary Physiology, Coronary Microvascular Dysfunction. Percutaneous coronary and cardiac interventions; complex, high-risk coronary interventions; intravascular imaging, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT); minimally invasive treatment of valvular heart disease; medical technology innovation

Awards & Honors

• 2019 First place, Adult Cardiology, 34th Annual Imperial Order Daughters of the Empire (IODE) Research Competition, University of Toronto
• 2010 Have a Heart Bursary Program Award, Canadian Cardiovascular Congress, Canadian Cardiovascular Society Academy 
• 2010 First place, Imaging for Cardiovascular Therapeutics Poster Competition, Imaging Network Ontario Symposium 

Innovations & Patents

• Innovations 
• 2020-present Reusable N95-equivalent full-face mask for COVID-19 pandemic
• 2007-present Hybrid intravascular ultrasound (IVUS) and optical coherence tomography (OCT) for intracoronary imaging
• 2012-2016 3D forward-viewing optical coherence tomography imaging (3D-OCT)
• 2007-2011 3D forward-viewing intracardiac echocardiography (3D-ICE)
• 2007 Cardiac magnetic resonance imaging (MRI) algorithm: 4D automated cardiac MRI segmentation
• 2005-2007 Interstitial Doppler optical coherence tomography (OCT) needle
• Patents
• Courtney BK, Munce NR, Thind AS, Yang VXD, Stuart Foster F, Soong A, Li BH, inventors; scanning mechanisms for imaging probe. United States patent US 8,460,195. 2013 Jun 11.

Memberships

• Fellow, Royal College of Physicians of Canada (FRCPC) in Cardiology and Internal Medicine
• American Heart Association
• American College of Cardiology
• Society for Cardiovascular Angiography and Interventions
• Canadian Cardiovascular Society

See publications for Brian Li, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/5/2023, Dr. Li has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Equity Dr. Li owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:

• Conavi Medical, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.